AUPH vs HRMY: stock comparison and AI forecast
Aurinia Pharmaceuticals Inc. (AUPH) and Harmony Biosciences Holdings, Inc. (HRMY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AUPH Aurinia Pharmaceuticals Inc.
- Price
- $16.65 +8.2% · 6M
- Market Cap
- $2.22B
- P/E Ratio
- 8.0x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
HRMY Harmony Biosciences Holdings, Inc.
- Price
- $37.91 +16.3% · 6M
- Market Cap
- $2.16B
- P/E Ratio
- 11.2x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AUPH and HRMY have similar market capitalizations ($2.22B and $2.16B).
- AUPH trades at 8.0 times trailing earnings, HRMY at 11.2 times.
- Over the last six months HRMY returned +16.3% and AUPH +8.2%.
- AUPH turns 97.7% of its revenue into net income, against 18.9% for HRMY.
- HRMY carries 0.37 times debt per unit of equity, against 0.26 times for AUPH.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AUPH | HRMY |
|---|---|---|
| Market Cap | $2.22B | $2.16B |
| P/E Ratio | 8.04x | 11.18x |
| P/B Ratio | 3.37x | 2.16x |
| EPS | $2.07 | $3.31 |
| Book Value/Share | $4.94 | $17.16 |
| Revenue/Share | $2.42 | $16.48 |
Profitability & Margins
| Metric | AUPH | HRMY |
|---|---|---|
| ROE | 47.8% | 18.1% |
| ROA | 38.1% | 13.2% |
| ROIC | 21.4% | 20.2% |
| Gross Margin | 90.6% | 75.4% |
| Operating Margin | 48.6% | 24.0% |
| Net Margin | 97.7% | 18.9% |
| EBT Margin | 51.9% | 25.1% |
| Tax Rate | -88.0% | 24.9% |
Financial Health
| Metric | AUPH | HRMY |
|---|---|---|
| Current Ratio | 6.12x | 3.48x |
| Quick Ratio | 5.67x | 3.45x |
| D/E Ratio | 0.26x | 0.37x |
| Financial Leverage | 1.26x | 1.37x |
| Interest Coverage | – | 29.1x |
| Working Capital | $492M | $580M |
Cash Flow
| Metric | AUPH | HRMY |
|---|---|---|
| Operating Cash Flow | $177M | $355M |
| OCF Growth YoY | 47.5% | 36.9% |
Operational Efficiency
| Metric | AUPH | HRMY |
|---|---|---|
| Asset Turnover | 0.39x | 0.70x |
| Receivables Turnover | – | 8.7x |
| Inventory Turnover | 0.7x | 37.1x |
| Fixed Assets Turnover | 185.2x | – |
| Days Sales Outstanding | – | 42 days |
| Days Inventory | 529 days | 10 days |
| Payables Period | 36 days | 34 days |
| Cash Conversion Cycle | – | 18 days |
Income Statement
| Metric | AUPH | HRMY |
|---|---|---|
| Total Revenue | $322M | $960M |
| Operating Income | $156M | $231M |
| Net Income | $314M | $181M |
| R&D Expense | $48M | $221M |
| SG&A Expense | – | $352M |
| Cost of Goods Sold | $30M | $236M |
Dividend & Shareholder Information
| Metric | AUPH | HRMY |
|---|---|---|
| Shares Outstanding | 133M | 58M |
| Net Income Growth | 303.8% | 0.2% |
| EPS Growth | 1117.7% | 10.7% |
AUPH vs HRMY: stock comparison and AI forecast
Which is bigger, AUPH or HRMY?
AUPH and HRMY have similar market capitalizations ($2.22B and $2.16B).
Which is cheaper on earnings, AUPH or HRMY?
AUPH trades at 8.0 times trailing earnings, HRMY at 11.2 times.
Which stock performed better over the last six months, AUPH or HRMY?
Over the last six months HRMY returned +16.3% and AUPH +8.2%.
Which one does Intratio's AI model rank higher, AUPH or HRMY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.